- LATEST
- WEBSTORY
- TRENDING
INDIA
Will Covid-19 nasal vaccine prove effective against infection? AIIMS expert says THIS
AIIMS expert Dr Sanjay Rai talked about the effectiveness of the Bharat Biotech nasal vaccine against the Covid-19 infection.
Updated : Jan 31, 2022, 01:17 PM IST
 "Will Covid-19 nasal vaccine prove effective against infection? AIIMS expert says THIS")
TRENDING NOW
)
Meet IAS officer, aka 'Collector Bro', who cracked UPSC exam in 2007, now suspended due to...
)
After Sushmita Sen declares she is single, Rohman Shawl's statement goes viral: 'Voh to 6 saal se...'
)
Meet star with no hit films, still earns Rs 5 lakh a month, is more famous than Aishwarya, Amitabh, Kareena, Ram Charan
)
Pakistani TikTok star Minahil Malik's dance video goes viral amid MMS leak controversy, watch
)
Badshah lands in legal trouble, case registered against rapper for...
)
'Der ho gayi...': Amitabh Bachchan posts cryptic tweet amid Abhishek Bachchan and Aishwarya Rai's divorce rumours
)
Kanguva box office collection day 1: Suriya, Bobby Deol film fails to beat Indian 2, Vettaiyan; earns Rs...
)
Shah Rukh Khan, Aamir Khan refused to work with Aishwarya Rai in this film, it became blockbuster, won 4 National Awards
)
'I haven't liked...': Abhishek Bachchan's statement on Aishwarya Rai's cooking goes viral amid divorce rumours
)
Meet actress who worked as sweeper, did superhit film with Shah Rukh, took up acting after Madhuri Dixit..., earns Rs..
)
Anushka Sharma laughs hard on Ranbir Kapoor's cringe 'sher' in viral video but gets annoyed after he...
)
Internet fuming over BIZZARE fan reaction in Diljit Dosanjh concert, netizens say, 'better if asteroid hit earth'
)
Shillong Teer Results November 15, 2024: Check updates on winning numbers
)
Meet Imsha Rehman, Pakistani TikTok star who deactivated her accounts after video leak and Minahil Malik's MMS
)
7 times XXX, Gandii Baat actress Aabha Paul crashed the internet by flaunting her sexy curves
As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay Rai, on Sunday said the vaccine could be a game-changer in the fight against the pandemic if it provides mucosal immunity.
"If this vaccine gives mucosal immunity, then it would be a great achievement for the human race. There are 33 vaccines all over the world but none is effective in preventing the infection. We are hoping that this vaccine will provide mucosal immunity that can prevent further infection," Dr Rai told ANI here.
As the Budget Session starts from Monday, the AIIMS Senior epidemiologist expects that need of the hour is to strengthen the public health system at all primary, secondary level, and tertiary levels.
"This is not the last pandemic, we must prepare for future pandemics, and to handle that, we need to strengthen the public health system," he said.
The Drugs Controller General of India (DCGI) has granted permission to Hyderabad-based biotechnology firm Bharat Biotech, the manufacturer of India's first indigenous COVID-19 vaccine Covaxin, for intranasal booster dose trials. The trials will be done at nine different sites.
Earlier this month, DCGI's Subject Expert Committee (SEC) had granted 'in-principle approval to Bharat Biotech for the conduct of 'Phase III superiority study and Phase III booster dose study' for its intranasal COVID vaccine BBV154.
